VSV infection and LPS treatment alter serum bile acid profiles, bile acid biosynthesis, and bile acid receptors in mice

被引:0
|
作者
Li, Yamei [1 ,2 ]
Luo, Yan [3 ]
Wang, Chao [3 ]
Xu, Lei [3 ]
Dai, Xinhua [1 ,2 ]
An, Yunfei [1 ,2 ]
He, Lin [3 ]
Zeng, Dongmei [3 ]
Bai, Yangjuan [1 ,2 ]
Zhang, Hua [3 ,4 ]
机构
[1] Sichuan Univ, West China Hosp, Med Res Ctr, Dept Lab Med,Clin Lab, Chengdu, Sichuan, Peoples R China
[2] Sichuan Clin Res Ctr Lab Med, Chengdu, Sichuan, Peoples R China
[3] Gen Hosp Western Theater Command, Dept Pathol, Chengdu, Sichuan, Peoples R China
[4] Gen Hosp Western Theater Command, Pancreat Injury & Repair Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
基金
中国国家自然科学基金;
关键词
VSV infection; LPS treatment; bile acid profiles; bile acid biosynthesis; bile acid receptors; HEPATITIS-B-VIRUS; VIRAL ENTRY; PHYSIOLOGY; EXPRESSION;
D O I
10.1128/spectrum.00836-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathogen infections remain a significant public health problem worldwide. Accumulating evidence regarding the crosstalk between bile acid (BA) metabolism and immune response reveals that BA metabolism regulates host immunity and microbial pathogenesis, making it an attractive target for disease prevention and infection control. However, the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors remains to be depicted. Here, we investigated the effect of viral (vesicular stomatitis virus, VSV) and bacterial (lipopolysaccharide, LPS) infections on BA metabolism and signaling. Infection models were successfully established by intraperitoneally injecting VSV and LPS, respectively. VSV and LPS injection significantly changed the circulating BA profiles, with highly increased levels of taurine-conjugated BAs and significant decreases in unconjugated BAs. Consistent with the decreased levels of circulating cholic acid (CA) and chenodeoxycholic acid (CDCA), the expression of BA biosynthesis-related rate-limiting enzymes (Cyp7a1, Cyp27a1, Cyp8b1, and Hsd3b7) were significantly reduced. Furthermore, hepatic and pulmonary BA receptors (BARs) expression varied in different infection models. LPS treatment had an extensive impact on tested hepatic and pulmonary BARs, resulting in the upregulation of TGR5, S1PR2, and VDR, while VSV infection only promoted VDR expression. Our study provides insights into the involvement of BA metabolism in the pathophysiology of infection, which may provide potential clues for targeting BA metabolism and BAR signaling to boost innate immunity and control infection.IMPORTANCEThis study focuses on the crosstalk between bile acid (BA) metabolism and immune response in VSV infection and LPS treatment models and depicts the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors. These findings provide insights into the effect of infection on BA metabolism and signaling, adding a more comprehensive understanding to the relationship between infection, BA metabolism and immune responses. This study focuses on the crosstalk between bile acid (BA) metabolism and immune response in VSV infection and LPS treatment models and depicts the effect of infection on circulating BA profiles, the biosynthesis-related enzymes, and their receptors. These findings provide insights into the effect of infection on BA metabolism and signaling, adding a more comprehensive understanding to the relationship between infection, BA metabolism and immune responses.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Hepatobiliary transport of bile acid amino acid, bile acid peptide, and bile acid oligonucleotide conjugates in rats
    Petzinger, E
    Wickboldt, A
    Pagels, P
    Starke, D
    Kramer, W
    HEPATOLOGY, 1999, 30 (05) : 1257 - 1268
  • [22] Mechanisms of bile acid inhibition of bile acid synthesis
    Chiang, JYL
    Li, T
    Spalding-Yoder, B
    Del Signore, S
    Bile Acid Biology and Its Therapeutic Implications, 2005, 141 : 51 - 58
  • [23] REGULATION OF BILE-ACID BIOSYNTHESIS
    SHEFER, S
    HAUSER, S
    MOSBACH, EH
    CIRCULATION, 1967, 36 (4S2) : II37 - &
  • [24] Bile Acid Replacement in Bile Acid Synthesis Defects
    Hofmann, Alan F.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (06): : E134 - 135
  • [25] The Ileal Bile Acid Transporter Inhibitor A4250 Modulates Bile Acid Synthesis and Decreases Serum Bile Acids
    Marschall, Hanns-Ulrich
    Gillberg, Per-Goeran
    Graffner, Hans
    Rikner, Leif
    HEPATOLOGY, 2015, 62 : 612A - 612A
  • [26] Nuclear receptors in bile acid metabolism
    Li, Tiangang
    Chiang, John Y. L.
    DRUG METABOLISM REVIEWS, 2013, 45 (01) : 145 - 155
  • [27] Bile acid treatment of gallstones
    Fromm, H
    HEPATOBILIARY DISEASES: CHOLESTASIS AND GALLSTONES, 2001, 117A : 143 - 145
  • [28] The bile acid of the bile of snakes.
    Deulofeu, V
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1934, 229 : 157 - 158
  • [29] Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice
    Winston, Jenessa A.
    Rivera, Alissa
    Cai, Jingwei
    Patterson, Andrew D.
    Theriot, Casey M.
    PLOS ONE, 2021, 16 (02):
  • [30] The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
    Kumar, Aditi
    Galbraith, Niall
    Al-Hassi, Hafid O.
    Jain, Manushri
    Phipps, Oliver
    Butterworth, Jeffrey
    Steed, Helen
    McLaughlin, John
    Brookes, Matthew J.
    BMC GASTROENTEROLOGY, 2022, 22 (01)